International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 1709-1710
Original Article
Neutrophil-to-Lymphocyte Ratio as an Inflammatory Marker Associated with Albuminuria in Patients with Diabetic Chronic Kidney Disease
 ,
Received
June 10, 2026
Accepted
July 5, 2026
Published
July 18, 2026
Abstract

Background: Chronic kidney disease (CKD) is a common and serious complication of diabetes mellitus, with inflammation playing a pivotal role in its progression. The Neutrophil-to-Lymphocyte Ratio (NLR), a simple and cost-effective inflammatory marker derived from routine blood investigations, has emerged as a potential indicator of systemic inflammation. Albuminuria is an established marker of renal damage and disease progression in diabetic CKD.

Objective: To evaluate the association between the Neutrophil-to-Lymphocyte Ratio and albuminuria in patients with diabetic chronic kidney disease.

Materials and Methods: A hospital-based cross-sectional observational study was conducted among 100 adult patients with type 2 diabetes mellitus and chronic kidney disease attending Silchar Medical College and Hospital. Clinical and laboratory parameters, including neutrophil count, lymphocyte count, serum creatinine, estimated glomerular filtration rate (eGFR), and urinary albumin levels, were recorded. NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. Statistical analysis was performed to determine the association between NLR and albuminuria, with a p-value <0.05 considered statistically significant.

Results: The mean age of the participants was approximately 57 years. The mean NLR was 3.09 ± 1.47, indicating the presence of chronic low-grade inflammation. The mean urinary albumin level was 273.03 ± 287.95 mg/g, with most patients demonstrating moderate albuminuria. Although higher NLR values were observed in patients with increased albuminuria, the association was not statistically significant.

Conclusion: Patients with diabetic CKD exhibited elevated NLR values suggestive of systemic inflammation. However, no significant association was observed between NLR and albuminuria in this study. NLR may still serve as an inexpensive and readily available inflammatory marker in diabetic CKD, although larger prospective studies are warranted to establish its prognostic significance.

Keywords
INTRODUCTION

 

Diabetes Mellitus is a major global health problem and one of the leading causes of Chronic Kidney Disease. Diabetic kidney disease is characterized by progressive renal damage resulting from chronic hyperglycemia, hemodynamic alterations, and inflammatory mechanisms.

Albuminuria is widely used as an early indicator of renal injury and reflects increased glomerular permeability. Persistent albuminuria is strongly associated with progression of kidney disease and increased cardiovascular risk.

Inflammation plays a central role in the development and progression of diabetic nephropathy. Recently, hematological indices derived from complete blood count have been explored as markers of systemic inflammation. Among these, the Neutrophil-to-Lymphocyte Ratio has gained attention due to its simplicity, cost-effectiveness, and clinical utility.

This study aimed to evaluate the association between NLR and albuminuria in patients with diabetic CKD.

 

MATERIALS AND METHODS

Study Design:

Hospital-based cross-sectional observational study.

Study Population:

100 patients with type 2 diabetes mellitus diagnosed with CKD attending Silchar Medical College and Hospital.

Inclusion Criteria

  • Patients with type 2 diabetes mellitus
  • Patients diagnosed with chronic kidney disease
  • Age >18 years

Exclusion Criteria

  • Acute infection
  • Malignancy
  • Autoimmune disorders
  • Patients on immunosuppressive therapy

Data Collection

Clinical and laboratory data were recorded including:

  • Total leukocyte count
  • Neutrophil count
  • Lymphocyte count
  • Serum creatinine
  • eGFR
  • Urinary albumin

Calculation
NLR = Neutrophil count / Lymphocyte count.

 

Statistical Analysis

Data were expressed as mean ± SD. Statistical tests were used to assess the association between NLR and albuminuria, with p < 0.05 considered statistically significant.

 

RESULTS

The study included 100 patients with diabetic CKD. The mean age of participants was approximately 57 years. The mean NLR was 3.09 ± 1.47, indicating a moderate inflammatory state.

Urinary albumin levels showed considerable variability with a mean value of 273.03 ± 287.95 mg/g. Most patients had moderate albuminuria.

Although higher NLR values were observed among patients with increased albuminuria levels, statistical analysis did not demonstrate a significant correlation between the two parameters.

 

DISCUSSION

The present study assessed the relationship between NLR and albuminuria in diabetic CKD patients. Elevated NLR values observed in our cohort suggest the presence of chronic low-grade inflammation.

Inflammation contributes to endothelial dysfunction and progressive glomerular damage in diabetic nephropathy. Albuminuria reflects structural renal injury and is widely recognized as an important marker of disease severity.

However, the absence of a significant association between NLR and albuminuria in our study may be attributed to the cross-sectional design and the predominance of patients with early to moderate CKD stages. Larger longitudinal studies may better clarify the predictive role of inflammatory markers such as NLR in diabetic kidney disease progression.

 

CONCLUSION

Patients with diabetic CKD demonstrate elevated NLR values indicating systemic inflammation. Although NLR did not show a strong association with albuminuria in this study, it may still serve as a simple and cost-effective inflammatory marker in diabetic kidney disease. Further research is required to evaluate its prognostic value.

 

REFERENCES

  1. Buonacera A, Neutrophil-to-lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. International Journal of Molecular Sciences. 2022;23:3636.
  2. Li X, Wang L, Liu M. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients. Frontiers in Endocrinology. 2024;14:1285509.
  3. Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults. JAMA. 2015;313(8):837-846.
Recommended Articles
Research Article Open Access
Evaluation of Clinical Profile, Laboratory Parameters, and Outcomes of Pediatric Dengue Infection: A Prospective Observational Study
2026, Volume-7, Issue 4 : 1803-1811
Research Article Open Access
Association of Body Mass Index Changes with Hematological Parameters and Alterations – A Cross Sectional Analysis
2026, Volume-7, Issue 4 : 1781-1786
Case Report Open Access
2026, Volume-7, Issue 4 : 1652-1654
Research Article Open Access
Insulin Resistance and Renal Magnesium Handling: Serum Magnesium Levels in Type 2 Diabetes Mellitus
2026, Volume-7, Issue 4 : 1767-1780
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
14 Views
1 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved